Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Huatan is a traditional Chinese medicine (TCM) formula used primarily in the form of a decoction or granule. It is widely prescribed for the treatment of colorectal cancer (CRC), particularly to reduce recurrence and metastasis after radical resection and adjuvant chemotherapy in stage III and high-risk stage II CRC patients. Clinical studies suggest it may also be effective for non-alcoholic fatty liver disease in children, with no observable toxic side effects reported. The mechanism of action is not fully elucidated but is believed to involve modulation of immune function, improvement of metabolic indices, reduction of inflammation, and enhancement of overall quality of life post-chemotherapy[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jianpi huatan.